Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels
Context: The Testosterone Trials are a coordinated set of seven trials to determine the efficacy of T in symptomatic men ≥65 years old with unequivocally low T levels. Initial results of the Sexual Function Trial showed that T improved sexual activity, sexual desire, and erectile function. Objective...
Gespeichert in:
Veröffentlicht in: | The journal of clinical endocrinology and metabolism 2016-08, Vol.101 (8), p.3096-3104 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3104 |
---|---|
container_issue | 8 |
container_start_page | 3096 |
container_title | The journal of clinical endocrinology and metabolism |
container_volume | 101 |
creator | Cunningham, Glenn R Stephens-Shields, Alisa J Rosen, Raymond C Wang, Christina Bhasin, Shalender Matsumoto, Alvin M Parsons, J. Kellogg Gill, Thomas M Molitch, Mark E Farrar, John T Cella, David Barrett-Connor, Elizabeth Cauley, Jane A Cifelli, Denise Crandall, Jill P Ensrud, Kristine E Gallagher, Laura Zeldow, Bret Lewis, Cora E Pahor, Marco Swerdloff, Ronald S Hou, Xiaoling Anton, Stephen Basaria, Shehzad Diem, Susan J Tabatabaie, Vafa Ellenberg, Susan S Snyder, Peter J |
description | Context:
The Testosterone Trials are a coordinated set of seven trials to determine the efficacy of T in symptomatic men ≥65 years old with unequivocally low T levels. Initial results of the Sexual Function Trial showed that T improved sexual activity, sexual desire, and erectile function.
Objective:
To assess the responsiveness of specific sexual activities to T treatment; to relate hormone changes to changes in sexual function; and to determine predictive baseline characteristics and T threshold for sexual outcomes.
Design:
A placebo-controlled trial.
Setting:
Twelve academic medical centers in the United States.
Participants:
A total of 470 men ≥65 years of age with low libido, average T |
doi_str_mv | 10.1210/jc.2016-1645 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4971331</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>27355400</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4738-8956df13493ff60abae3ad1f3b1d597116f5a0212c76497239fe9dfd785080ff3</originalsourceid><addsrcrecordid>eNptkEFPGzEQha0K1IS0t56RfwBLPWt7vXupVCEolYI4EERvlrMeNxs2dmTvkvLv6ygtAglLlg9-75t5j5AvwM6hBPZ13Z6XDKoCKiE_kCk0QhYKGnVEpoyVUDSq_DUhJymtGQMhJP9IJqXiUgrGpmSxwDSENGAMHukiohk26AdqvKV3-Gc0Pb0afTt0wdPO09veYqQ36OlDN6zoPOzoG8Acn7BPn8ixM33Cz__eGbm_ulxcXBfz2x8_L77Pi1YoXhd1IyvrgIuGO1cxszTIjQXHl2BlowAqJ02OULaqEjkGbxw21llVS1Yz5_iMfDtwt-Nyg7bNi0fT623sNiY-62A6_fbHdyv9OzzpTAPOIQPODoA2hpQiuhcvML1vV69bvW9X79vN8tPX817E_-vMAnEQ7EKfG0mP_bjDqFdo-mGlWT6iUnWxJ-YEjBX5Qp1t_GBDb0MbO4_biCnpdRijzwW-v81fNliXlA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><source>Oxford Journals</source><source>Journals@Ovid Complete</source><creator>Cunningham, Glenn R ; Stephens-Shields, Alisa J ; Rosen, Raymond C ; Wang, Christina ; Bhasin, Shalender ; Matsumoto, Alvin M ; Parsons, J. Kellogg ; Gill, Thomas M ; Molitch, Mark E ; Farrar, John T ; Cella, David ; Barrett-Connor, Elizabeth ; Cauley, Jane A ; Cifelli, Denise ; Crandall, Jill P ; Ensrud, Kristine E ; Gallagher, Laura ; Zeldow, Bret ; Lewis, Cora E ; Pahor, Marco ; Swerdloff, Ronald S ; Hou, Xiaoling ; Anton, Stephen ; Basaria, Shehzad ; Diem, Susan J ; Tabatabaie, Vafa ; Ellenberg, Susan S ; Snyder, Peter J</creator><creatorcontrib>Cunningham, Glenn R ; Stephens-Shields, Alisa J ; Rosen, Raymond C ; Wang, Christina ; Bhasin, Shalender ; Matsumoto, Alvin M ; Parsons, J. Kellogg ; Gill, Thomas M ; Molitch, Mark E ; Farrar, John T ; Cella, David ; Barrett-Connor, Elizabeth ; Cauley, Jane A ; Cifelli, Denise ; Crandall, Jill P ; Ensrud, Kristine E ; Gallagher, Laura ; Zeldow, Bret ; Lewis, Cora E ; Pahor, Marco ; Swerdloff, Ronald S ; Hou, Xiaoling ; Anton, Stephen ; Basaria, Shehzad ; Diem, Susan J ; Tabatabaie, Vafa ; Ellenberg, Susan S ; Snyder, Peter J</creatorcontrib><description>Context:
The Testosterone Trials are a coordinated set of seven trials to determine the efficacy of T in symptomatic men ≥65 years old with unequivocally low T levels. Initial results of the Sexual Function Trial showed that T improved sexual activity, sexual desire, and erectile function.
Objective:
To assess the responsiveness of specific sexual activities to T treatment; to relate hormone changes to changes in sexual function; and to determine predictive baseline characteristics and T threshold for sexual outcomes.
Design:
A placebo-controlled trial.
Setting:
Twelve academic medical centers in the United States.
Participants:
A total of 470 men ≥65 years of age with low libido, average T <275 ng/dL, and a partner willing to have sexual intercourse at least twice a month.
Methods:
Men were assigned to take T gel or placebo for 1 year. Sexual function was assessed by three questionnaires every 3 months: the Psychosexual Daily Questionnaire, the Derogatis Interview for Sexual Function, and the International Index of Erectile Function.
Results:
Compared with placebo, T administration significantly improved 10 of 12 measures of sexual activity. Incremental increases in total and free T and estradiol levels were associated with improvements in sexual activity and desire, but not erectile function. No threshold T level was observed for any outcome, and none of the 27 baseline characteristics predicted responsiveness to T.
Conclusions:
In older men with low libido and low T levels, improvements in sexual desire and activity in response to T treatment were related to the magnitude of increases in T and estradiol levels, but there was no clear evidence of a threshold effect.
Testosterone Treatment and Sexual Function in Older Men with Low Testosterone Levels. Improvements in sexual desire and activity were related to the magnitude of increases in testosterone.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jc.2016-1645</identifier><identifier>PMID: 27355400</identifier><language>eng</language><publisher>United States: Endocrine Society</publisher><subject>Aged ; Erectile Dysfunction - drug therapy ; Hormone Replacement Therapy ; Humans ; Libido - drug effects ; Male ; Original ; Placebos ; Sexual Behavior - drug effects ; Sexual Dysfunction, Physiological - blood ; Sexual Dysfunction, Physiological - drug therapy ; Sexual Dysfunction, Physiological - physiopathology ; Surveys and Questionnaires ; Testosterone - blood ; Testosterone - therapeutic use ; Treatment Outcome</subject><ispartof>The journal of clinical endocrinology and metabolism, 2016-08, Vol.101 (8), p.3096-3104</ispartof><rights>Copyright © 2016 by the Endocrine Society</rights><rights>Copyright © 2016 by The Endocrine Society</rights><rights>Copyright © 2016 by the Endocrine Society 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4738-8956df13493ff60abae3ad1f3b1d597116f5a0212c76497239fe9dfd785080ff3</citedby><cites>FETCH-LOGICAL-c4738-8956df13493ff60abae3ad1f3b1d597116f5a0212c76497239fe9dfd785080ff3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27355400$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cunningham, Glenn R</creatorcontrib><creatorcontrib>Stephens-Shields, Alisa J</creatorcontrib><creatorcontrib>Rosen, Raymond C</creatorcontrib><creatorcontrib>Wang, Christina</creatorcontrib><creatorcontrib>Bhasin, Shalender</creatorcontrib><creatorcontrib>Matsumoto, Alvin M</creatorcontrib><creatorcontrib>Parsons, J. Kellogg</creatorcontrib><creatorcontrib>Gill, Thomas M</creatorcontrib><creatorcontrib>Molitch, Mark E</creatorcontrib><creatorcontrib>Farrar, John T</creatorcontrib><creatorcontrib>Cella, David</creatorcontrib><creatorcontrib>Barrett-Connor, Elizabeth</creatorcontrib><creatorcontrib>Cauley, Jane A</creatorcontrib><creatorcontrib>Cifelli, Denise</creatorcontrib><creatorcontrib>Crandall, Jill P</creatorcontrib><creatorcontrib>Ensrud, Kristine E</creatorcontrib><creatorcontrib>Gallagher, Laura</creatorcontrib><creatorcontrib>Zeldow, Bret</creatorcontrib><creatorcontrib>Lewis, Cora E</creatorcontrib><creatorcontrib>Pahor, Marco</creatorcontrib><creatorcontrib>Swerdloff, Ronald S</creatorcontrib><creatorcontrib>Hou, Xiaoling</creatorcontrib><creatorcontrib>Anton, Stephen</creatorcontrib><creatorcontrib>Basaria, Shehzad</creatorcontrib><creatorcontrib>Diem, Susan J</creatorcontrib><creatorcontrib>Tabatabaie, Vafa</creatorcontrib><creatorcontrib>Ellenberg, Susan S</creatorcontrib><creatorcontrib>Snyder, Peter J</creatorcontrib><title>Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>Context:
The Testosterone Trials are a coordinated set of seven trials to determine the efficacy of T in symptomatic men ≥65 years old with unequivocally low T levels. Initial results of the Sexual Function Trial showed that T improved sexual activity, sexual desire, and erectile function.
Objective:
To assess the responsiveness of specific sexual activities to T treatment; to relate hormone changes to changes in sexual function; and to determine predictive baseline characteristics and T threshold for sexual outcomes.
Design:
A placebo-controlled trial.
Setting:
Twelve academic medical centers in the United States.
Participants:
A total of 470 men ≥65 years of age with low libido, average T <275 ng/dL, and a partner willing to have sexual intercourse at least twice a month.
Methods:
Men were assigned to take T gel or placebo for 1 year. Sexual function was assessed by three questionnaires every 3 months: the Psychosexual Daily Questionnaire, the Derogatis Interview for Sexual Function, and the International Index of Erectile Function.
Results:
Compared with placebo, T administration significantly improved 10 of 12 measures of sexual activity. Incremental increases in total and free T and estradiol levels were associated with improvements in sexual activity and desire, but not erectile function. No threshold T level was observed for any outcome, and none of the 27 baseline characteristics predicted responsiveness to T.
Conclusions:
In older men with low libido and low T levels, improvements in sexual desire and activity in response to T treatment were related to the magnitude of increases in T and estradiol levels, but there was no clear evidence of a threshold effect.
Testosterone Treatment and Sexual Function in Older Men with Low Testosterone Levels. Improvements in sexual desire and activity were related to the magnitude of increases in testosterone.</description><subject>Aged</subject><subject>Erectile Dysfunction - drug therapy</subject><subject>Hormone Replacement Therapy</subject><subject>Humans</subject><subject>Libido - drug effects</subject><subject>Male</subject><subject>Original</subject><subject>Placebos</subject><subject>Sexual Behavior - drug effects</subject><subject>Sexual Dysfunction, Physiological - blood</subject><subject>Sexual Dysfunction, Physiological - drug therapy</subject><subject>Sexual Dysfunction, Physiological - physiopathology</subject><subject>Surveys and Questionnaires</subject><subject>Testosterone - blood</subject><subject>Testosterone - therapeutic use</subject><subject>Treatment Outcome</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkEFPGzEQha0K1IS0t56RfwBLPWt7vXupVCEolYI4EERvlrMeNxs2dmTvkvLv6ygtAglLlg9-75t5j5AvwM6hBPZ13Z6XDKoCKiE_kCk0QhYKGnVEpoyVUDSq_DUhJymtGQMhJP9IJqXiUgrGpmSxwDSENGAMHukiohk26AdqvKV3-Gc0Pb0afTt0wdPO09veYqQ36OlDN6zoPOzoG8Acn7BPn8ixM33Cz__eGbm_ulxcXBfz2x8_L77Pi1YoXhd1IyvrgIuGO1cxszTIjQXHl2BlowAqJ02OULaqEjkGbxw21llVS1Yz5_iMfDtwt-Nyg7bNi0fT623sNiY-62A6_fbHdyv9OzzpTAPOIQPODoA2hpQiuhcvML1vV69bvW9X79vN8tPX817E_-vMAnEQ7EKfG0mP_bjDqFdo-mGlWT6iUnWxJ-YEjBX5Qp1t_GBDb0MbO4_biCnpdRijzwW-v81fNliXlA</recordid><startdate>201608</startdate><enddate>201608</enddate><creator>Cunningham, Glenn R</creator><creator>Stephens-Shields, Alisa J</creator><creator>Rosen, Raymond C</creator><creator>Wang, Christina</creator><creator>Bhasin, Shalender</creator><creator>Matsumoto, Alvin M</creator><creator>Parsons, J. Kellogg</creator><creator>Gill, Thomas M</creator><creator>Molitch, Mark E</creator><creator>Farrar, John T</creator><creator>Cella, David</creator><creator>Barrett-Connor, Elizabeth</creator><creator>Cauley, Jane A</creator><creator>Cifelli, Denise</creator><creator>Crandall, Jill P</creator><creator>Ensrud, Kristine E</creator><creator>Gallagher, Laura</creator><creator>Zeldow, Bret</creator><creator>Lewis, Cora E</creator><creator>Pahor, Marco</creator><creator>Swerdloff, Ronald S</creator><creator>Hou, Xiaoling</creator><creator>Anton, Stephen</creator><creator>Basaria, Shehzad</creator><creator>Diem, Susan J</creator><creator>Tabatabaie, Vafa</creator><creator>Ellenberg, Susan S</creator><creator>Snyder, Peter J</creator><general>Endocrine Society</general><general>Copyright by The Endocrine Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>201608</creationdate><title>Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels</title><author>Cunningham, Glenn R ; Stephens-Shields, Alisa J ; Rosen, Raymond C ; Wang, Christina ; Bhasin, Shalender ; Matsumoto, Alvin M ; Parsons, J. Kellogg ; Gill, Thomas M ; Molitch, Mark E ; Farrar, John T ; Cella, David ; Barrett-Connor, Elizabeth ; Cauley, Jane A ; Cifelli, Denise ; Crandall, Jill P ; Ensrud, Kristine E ; Gallagher, Laura ; Zeldow, Bret ; Lewis, Cora E ; Pahor, Marco ; Swerdloff, Ronald S ; Hou, Xiaoling ; Anton, Stephen ; Basaria, Shehzad ; Diem, Susan J ; Tabatabaie, Vafa ; Ellenberg, Susan S ; Snyder, Peter J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4738-8956df13493ff60abae3ad1f3b1d597116f5a0212c76497239fe9dfd785080ff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aged</topic><topic>Erectile Dysfunction - drug therapy</topic><topic>Hormone Replacement Therapy</topic><topic>Humans</topic><topic>Libido - drug effects</topic><topic>Male</topic><topic>Original</topic><topic>Placebos</topic><topic>Sexual Behavior - drug effects</topic><topic>Sexual Dysfunction, Physiological - blood</topic><topic>Sexual Dysfunction, Physiological - drug therapy</topic><topic>Sexual Dysfunction, Physiological - physiopathology</topic><topic>Surveys and Questionnaires</topic><topic>Testosterone - blood</topic><topic>Testosterone - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cunningham, Glenn R</creatorcontrib><creatorcontrib>Stephens-Shields, Alisa J</creatorcontrib><creatorcontrib>Rosen, Raymond C</creatorcontrib><creatorcontrib>Wang, Christina</creatorcontrib><creatorcontrib>Bhasin, Shalender</creatorcontrib><creatorcontrib>Matsumoto, Alvin M</creatorcontrib><creatorcontrib>Parsons, J. Kellogg</creatorcontrib><creatorcontrib>Gill, Thomas M</creatorcontrib><creatorcontrib>Molitch, Mark E</creatorcontrib><creatorcontrib>Farrar, John T</creatorcontrib><creatorcontrib>Cella, David</creatorcontrib><creatorcontrib>Barrett-Connor, Elizabeth</creatorcontrib><creatorcontrib>Cauley, Jane A</creatorcontrib><creatorcontrib>Cifelli, Denise</creatorcontrib><creatorcontrib>Crandall, Jill P</creatorcontrib><creatorcontrib>Ensrud, Kristine E</creatorcontrib><creatorcontrib>Gallagher, Laura</creatorcontrib><creatorcontrib>Zeldow, Bret</creatorcontrib><creatorcontrib>Lewis, Cora E</creatorcontrib><creatorcontrib>Pahor, Marco</creatorcontrib><creatorcontrib>Swerdloff, Ronald S</creatorcontrib><creatorcontrib>Hou, Xiaoling</creatorcontrib><creatorcontrib>Anton, Stephen</creatorcontrib><creatorcontrib>Basaria, Shehzad</creatorcontrib><creatorcontrib>Diem, Susan J</creatorcontrib><creatorcontrib>Tabatabaie, Vafa</creatorcontrib><creatorcontrib>Ellenberg, Susan S</creatorcontrib><creatorcontrib>Snyder, Peter J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cunningham, Glenn R</au><au>Stephens-Shields, Alisa J</au><au>Rosen, Raymond C</au><au>Wang, Christina</au><au>Bhasin, Shalender</au><au>Matsumoto, Alvin M</au><au>Parsons, J. Kellogg</au><au>Gill, Thomas M</au><au>Molitch, Mark E</au><au>Farrar, John T</au><au>Cella, David</au><au>Barrett-Connor, Elizabeth</au><au>Cauley, Jane A</au><au>Cifelli, Denise</au><au>Crandall, Jill P</au><au>Ensrud, Kristine E</au><au>Gallagher, Laura</au><au>Zeldow, Bret</au><au>Lewis, Cora E</au><au>Pahor, Marco</au><au>Swerdloff, Ronald S</au><au>Hou, Xiaoling</au><au>Anton, Stephen</au><au>Basaria, Shehzad</au><au>Diem, Susan J</au><au>Tabatabaie, Vafa</au><au>Ellenberg, Susan S</au><au>Snyder, Peter J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2016-08</date><risdate>2016</risdate><volume>101</volume><issue>8</issue><spage>3096</spage><epage>3104</epage><pages>3096-3104</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><abstract>Context:
The Testosterone Trials are a coordinated set of seven trials to determine the efficacy of T in symptomatic men ≥65 years old with unequivocally low T levels. Initial results of the Sexual Function Trial showed that T improved sexual activity, sexual desire, and erectile function.
Objective:
To assess the responsiveness of specific sexual activities to T treatment; to relate hormone changes to changes in sexual function; and to determine predictive baseline characteristics and T threshold for sexual outcomes.
Design:
A placebo-controlled trial.
Setting:
Twelve academic medical centers in the United States.
Participants:
A total of 470 men ≥65 years of age with low libido, average T <275 ng/dL, and a partner willing to have sexual intercourse at least twice a month.
Methods:
Men were assigned to take T gel or placebo for 1 year. Sexual function was assessed by three questionnaires every 3 months: the Psychosexual Daily Questionnaire, the Derogatis Interview for Sexual Function, and the International Index of Erectile Function.
Results:
Compared with placebo, T administration significantly improved 10 of 12 measures of sexual activity. Incremental increases in total and free T and estradiol levels were associated with improvements in sexual activity and desire, but not erectile function. No threshold T level was observed for any outcome, and none of the 27 baseline characteristics predicted responsiveness to T.
Conclusions:
In older men with low libido and low T levels, improvements in sexual desire and activity in response to T treatment were related to the magnitude of increases in T and estradiol levels, but there was no clear evidence of a threshold effect.
Testosterone Treatment and Sexual Function in Older Men with Low Testosterone Levels. Improvements in sexual desire and activity were related to the magnitude of increases in testosterone.</abstract><cop>United States</cop><pub>Endocrine Society</pub><pmid>27355400</pmid><doi>10.1210/jc.2016-1645</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-972X |
ispartof | The journal of clinical endocrinology and metabolism, 2016-08, Vol.101 (8), p.3096-3104 |
issn | 0021-972X 1945-7197 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4971331 |
source | MEDLINE; Alma/SFX Local Collection; EZB Electronic Journals Library; Oxford Journals; Journals@Ovid Complete |
subjects | Aged Erectile Dysfunction - drug therapy Hormone Replacement Therapy Humans Libido - drug effects Male Original Placebos Sexual Behavior - drug effects Sexual Dysfunction, Physiological - blood Sexual Dysfunction, Physiological - drug therapy Sexual Dysfunction, Physiological - physiopathology Surveys and Questionnaires Testosterone - blood Testosterone - therapeutic use Treatment Outcome |
title | Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T19%3A58%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Testosterone%20Treatment%20and%20Sexual%20Function%20in%20Older%20Men%20With%20Low%20Testosterone%20Levels&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=Cunningham,%20Glenn%20R&rft.date=2016-08&rft.volume=101&rft.issue=8&rft.spage=3096&rft.epage=3104&rft.pages=3096-3104&rft.issn=0021-972X&rft.eissn=1945-7197&rft_id=info:doi/10.1210/jc.2016-1645&rft_dat=%3Cpubmed_cross%3E27355400%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/27355400&rfr_iscdi=true |